191 related articles for article (PubMed ID: 30174245)
1. Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?
Rüegger AD; Coleman L; Hansford JR; McLean N; Dabscheck G
Pediatr Neurol; 2018 Sep; 86():63-65. PubMed ID: 30174245
[TBL] [Abstract][Full Text] [Related]
2. Medullary unidentified bright objects in Neurofibromatosis type 1: a case series.
D'Amico A; Mazio F; Ugga L; Cuocolo R; Cirillo M; Santoro C; Perrotta S; Melis D; Brunetti A
BMC Pediatr; 2018 Feb; 18(1):91. PubMed ID: 29490631
[TBL] [Abstract][Full Text] [Related]
3. MR imaging of neoplastic and non-neoplastic lesions of the brain and spine in neurofibromatosis type I.
Razek AAKA
Neurol Sci; 2018 May; 39(5):821-827. PubMed ID: 29455398
[TBL] [Abstract][Full Text] [Related]
4. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
[TBL] [Abstract][Full Text] [Related]
5. Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging.
Eby NS; Griffith JL; Gutmann DH; Morris SM
Dev Med Child Neurol; 2019 Aug; 61(8):972-978. PubMed ID: 30659594
[TBL] [Abstract][Full Text] [Related]
6. Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.
Sabol Z; Resić B; Gjergja Juraski R; Sabol F; Kovac Sizgorić M; Orsolić K; Ozretić D; Sepić-Grahovac D
Croat Med J; 2011 Aug; 52(4):488-96. PubMed ID: 21853543
[TBL] [Abstract][Full Text] [Related]
7. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function.
Goh WH; Khong PL; Leung CS; Wong VC
J Child Neurol; 2004 Nov; 19(11):853-8. PubMed ID: 15658789
[TBL] [Abstract][Full Text] [Related]
8. Benign longitudinal T2-hyperintense signal in the lateral cord in infancy: a cross-sectional study of spinal cord white matter maturation on magnetic resonance imaging.
Weidman EK; Zandifar A; Vossough A
Pediatr Radiol; 2021 Oct; 51(11):2069-2076. PubMed ID: 34143226
[TBL] [Abstract][Full Text] [Related]
9. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
[TBL] [Abstract][Full Text] [Related]
10. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
[TBL] [Abstract][Full Text] [Related]
11. MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.
Rosenbaum T; Engelbrecht V; Krölls W; van Dorsten FA; Hoehn-Berlage M; Lenard HG
Brain Dev; 1999 Jun; 21(4):268-73. PubMed ID: 10392751
[TBL] [Abstract][Full Text] [Related]
12. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
[TBL] [Abstract][Full Text] [Related]
13. Ganglioglioma of the spinal cord in neurofibromatosis type 1.
Giussani C; Isimbaldi G; Massimino M; Trezza A; Cianci P; Canonico F; Sganzerla EP
Pediatr Neurosurg; 2013; 49(1):50-4. PubMed ID: 24192615
[TBL] [Abstract][Full Text] [Related]
14. C2 neurofibromas in neurofibromatosis type 1: genetic and imaging characteristics.
Waqar M; Huson S; Evans DG; Ealing J; Karabatsou K; George KJ; Soh C
J Neurosurg Spine; 2018 Oct; 30(1):126-132. PubMed ID: 30485203
[TBL] [Abstract][Full Text] [Related]
15. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
[TBL] [Abstract][Full Text] [Related]
16. Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI.
Calvez S; Levy R; Calvez R; Roux CJ; Grévent D; Purcell Y; Beccaria K; Blauwblomme T; Grill J; Dufour C; Bourdeaut F; Doz F; Robert MP; Boddaert N; Dangouloff-Ros V
AJNR Am J Neuroradiol; 2020 Sep; 41(9):1733-1739. PubMed ID: 32816766
[TBL] [Abstract][Full Text] [Related]
17. A Review of Spinal Lesions in Neurofibromatosis Type 1 in a Large Neurofibromatosis Type 1 Center.
Sial M; George KJ
World Neurosurg; 2023 Jan; 169():e157-e163. PubMed ID: 36334707
[TBL] [Abstract][Full Text] [Related]
18. Using a semi-automated approach to quantify Unidentified Bright Objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes.
Harriott EM; Nguyen TQ; Landman BA; Barquero LA; Cutting LE
Magn Reson Imaging; 2023 May; 98():17-25. PubMed ID: 36608909
[TBL] [Abstract][Full Text] [Related]
19. The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis.
Di Stasi M; Cocozza S; Buccino S; Paolella C; Di Napoli L; D'Amico A; Melis D; Ugga L; Villano G; Ruocco M; Scala I; Brunetti A; Elefante A
Acta Neurol Belg; 2024 Feb; 124(1):223-230. PubMed ID: 37733157
[TBL] [Abstract][Full Text] [Related]
20. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
